youtube_live
Q2 2027 earnings • released • EPS beat +15,03% • Revenue beat +6,35%
See resultschevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 224,80 ₹
arrow_downward
-0,90%(-20,20) 1D
6 նոյ, 11:27:48 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 224,20 ₹
High
2 233,10 ₹
Low
2 181,10 ₹
Mkt. cap
422,28 մլրդ
Avg. vol.
178,84 հզր
Volume
60,67 հզր
Dividend
0,16%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
46,70
52-wk high
2 266,40 ₹
52-wk low
1 312,30 ₹
EPS
47,64 ₹
No. of employees
7 հզր
Open
2 224,20 ₹
High
2 233,10 ₹
Low
2 181,10 ₹
Mkt. cap
422,28 մլրդ
Avg. vol.
178,84 հզր
Volume
60,67 հզր
Dividend
0,16%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
46,70
52-wk high
2 266,40 ₹
52-wk low
1 312,30 ₹
EPS
47,64 ₹
No. of employees
7 հզր
News stories
From web sources and news partners
Yahoo Finance
·
20 ժամ առաջ
Emcure Pharmaceuticals Ltd (BOM:544210) (Q2 2027) Earnings Call Highlights: Revenue Jumps 24% ...
Investing.com
·
2 օր առաջ
Emcure Q2FY27 slides: profit growth outpaces revenue on margin gains
Investing.com
·
2 օր առաջ
Earnings call transcript: Emcure lifts FY27 outlook as Q2 profit jumps
TradingView
·
2 օր առաջ
EMCURE: Revenue rose 24.3% as EBITDA and PAT growth outpaced sales
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 հզր
Founded16 ապր, 1981 թ.
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com